About 90% of men who undergo prostate cancer treatment, and nearly 50% of men treated for other cancers, experience some degree of sexual dysfunction or erectile challenges, according to recent data. Yet most patients rarely discuss these issues, suffering in silence when help is available. Experts emphasize that sexual health problems linked to cancer treatment are treatable, and men should not hesitate to seek support.
The statistics highlight a significant gap in cancer care. While medical advancements focus on improving survival rates and reducing side effects, the emotional and relational impact of sexual dysfunction often goes unaddressed. For many men, the inability to maintain sexual function after treatment can lead to depression, anxiety, and strained relationships. However, healthcare providers point out that there are multiple strategies—from medications to counseling and mechanical devices—that can help restore sexual health.
As the quest for better cancer treatments with minimal side effects continues at companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI), there is hope that future therapies may reduce the incidence of sexual side effects. In the meantime, patients are encouraged to communicate openly with their oncology teams about any concerns.
The findings underscore the need for a more holistic approach to cancer care that includes sexual health as a standard component of treatment planning. Prostate cancer alone affects over 200,000 men annually in the United States, making this a widespread issue. By integrating sexual health discussions into routine oncology visits, clinicians can help patients maintain quality of life during and after treatment.
Organizations like the American Cancer Society offer resources for patients and partners, emphasizing that sexual problems are common and manageable. Support groups and specialized clinics also provide safe spaces for men to share experiences and solutions. The key takeaway is that no one should have to face these challenges alone.
For more information on cancer treatment side effects and support, visit BioMedWire, a platform covering developments in biotechnology and life sciences. BioMedWire is a brand within the Dynamic Brand Portfolio @IBN that delivers access to a vast network of wire solutions and editorial syndication to over 5,000 outlets.
